Immune Thrombocytopenic Purpura
📧 Sign up to get email alerts when something new happens for Immune Thrombocytopenic Purpura.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-28Clinical Trial Update: A Clinical Study on the Efficacy and Safety of HBM9161 in Patients With ITP [Phase 2, Phase 3]
A completed Phase 2/3 clinical trial evaluating the efficacy and safety of HBM9161 in patients with primary immune thrombocytopenic purpura …
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Development and Prospective Validation of an AI Model for Prognosis in ITP Patients Undergoing Coronary Revascularization
This clinical trial update describes development and prospective validation of an AI model to predict prognosis in patients with immune thro…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Physical Fitness of Children, Adolescents and Young Adults With Immune Thrombocytopenic Purpura [NA]
A ClinicalTrials.gov entry details a study led by University Hospital, Bordeaux to evaluate physical fitness in children, adolescents and yo…
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: Helicobacter Pylori Eradication Therapy for Immune Thrombocytopenia (ITP) Patients in Iraq [NA]
A completed clinical trial from Al-Mustansiriyah University evaluated Helicobacter pylori eradication therapy in patients with immune thromb…
-
CLINICAL_TRIALS trial_result · 2025-07-17Clinical Trial Update: Prevalence of Thyroid Disorders in Patients With Immune Thrombocytopenic Purpura and Its Impact on Treatment
This clinical trial investigates the prevalence of thyroid disorders in patients with immune thrombocytopenic purpura. It also examines how …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: A Study of PN20 in Healthy Adult Volunteers [Phase 1]
Phase 1 study of PN20 in healthy adult volunteers has been completed; the trial investigated dosing in conditions including chemotherapy-ind…
-
CLINICAL_TRIALS trial_result · 2024-12-16Clinical Trial Update: Oral LGD-4665 Versus Placebo in Adults With Immune Thrombocytopenic Purpura (ITP) for 6 Weeks Plus Open Treatment Continuation [Phase 2]
Phase 2 trial of oral LGD-4665 vs placebo in adults with immune thrombocytopenic purpura has completed.
-
CLINICAL_TRIALS other · 2024-09-19Clinical Trial Update: Steroid Resistance in Pediatric Immune Thrombocytopenic Purpura
This ClinicalTrials.gov entry from Assiut University describes a study on steroid resistance in pediatric immune thrombocytopenic purpura. T…
-
CLINICAL_TRIALS trial_result · 2024-07-01Clinical Trial Update: Safety and Tolerability of M254 in Healthy Volunteers and Immune Thrombocytopenic Purpura (ITP) Patients [Phase 1, Phase 2]
Phase 1/Phase 2 clinical trial update shows safety and tolerability data for M254 in healthy volunteers and patients with Immune Thrombocyto…
-
CLINICAL_TRIALS trial_result · 2024-03-15Clinical Trial Update: Multiple Rising Does Study (Subcutaneous Doses) of BI 655064 in Male and Female Patients With Chronic Primary Immune Thrombocytopenic Purpura (ITP). [Phase 1]
Phase 1 trial of BI 655064 for chronic primary immune thrombocytopenic purpura (ITP) in adults was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2023-12-27Clinical Trial Update: A Study to Assess the Ability of Eltrombopag to Induce Sustained Response Off Treatment in Subjects With ITP [Phase 2]
Phase 2 trial evaluating eltrombopag's ability to induce a sustained off-treatment response in subjects with immune thrombocytopenic purpura…
-
CLINICAL_TRIALS trial_result · 2023-12-11Clinical Trial Update: Open Label Study of R788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP) [Phase 3]
Open-label Phase 3 trial investigating R788 for persistent/chronic immune thrombocytopenic purpura (ITP) has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-08-24Clinical Trial Update: Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders [Phase 3]
Phase 3 safety and efficacy study of a 10% intravenous immunoglobulin solution in subjects with primary immunodeficiency disorders has compl…
-
CLINICAL_TRIALS trial_result · 2021-05-03Clinical Trial Update: Efficacy and Safety Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Adult Subjects With Chronic Idiopathic Thrombocytopenic Purpura [Phase 2]
Phase 2 trial updating efficacy and safety of a 10% triple virally reduced intravenous immunoglobulin in adults with chronic immune thromboc…
-
CLINICAL_TRIALS trial_result · 2021-02-10Clinical Trial Update: A Clinical Study on the Efficacy and Safety of HBM9161 in Patients With ITP [Phase 2, Phase 3]
A Clinical Trial Update reporting phase 2/phase 3 study of HBM9161 in patients with primary immune thrombocytopenic purpura (ITP).
-
CLINICAL_TRIALS trial_result · 2020-09-09Clinical Trial Update: A Trial of Eltrombopag or Intravenous Immune Globulin Before Surgery for Immune Thrombocytopenia Patients [Phase 3]
Phase 3 trial comparing eltrombopag to IVIG before surgery in immune thrombocytopenia patients completed.
-
CLINICAL_TRIALS trial_result · 2019-12-20Clinical Trial Update: Amgen Megakaryopoiesis Protein 2 (AMG 531) in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura (ITP) [Phase 1, Phase 2]
Clinical trial update for AMG 531 (Megakaryopoiesis Protein 2) in thrombocytopenic subjects with immune thrombocytopenic purpura (ITP) compl…
-
CLINICAL_TRIALS research · 2019-08-28Clinical Trial Update: Initial Hemato-immunological Profile on the Evolution of Immunological Thrombopenic Purpura. [Phase 3]
Phase 3 clinical trial assessing hematologic and immunological profiles in immune thrombocytopenic purpura (ITP) exploring evolution of the …
-
CLINICAL_TRIALS trial_result · 2019-07-05Clinical Trial Update: A Long-term Safety Study of Eltrombopag in Pediatric Patients With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP) [Phase 3]
Phase 3 long-term safety study of eltrombopag in pediatric patients with chronic idiopathic thrombocytopenic purpura completed; results post…
-
CLINICAL_TRIALS trial_result · 2019-04-01Clinical Trial Update: Study to Evaluate Safety and Efficacy in Adult Subjects With ITP [Phase 1, Phase 2]
Clinical trial evaluating safety and efficacy in adults with immune thrombocytopenic purpura completed; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-01-30Clinical Trial Update: Open Label Trial on the Safety and Efficacy of Sym001 in the Treatment of Immune Thrombocytopenic Purpura (ITP) [Phase 2]
Open-label Phase 2 trial assessing the safety and efficacy of Sym001 for Immune Thrombocytopenic Purpura has completed.
-
CLINICAL_TRIALS trial_result · 2019-01-25Clinical Trial Update: A Efficacy and Safety Study of Fostamatinib in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP) [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of fostamatinib in persistent/chronic immune thrombocytopenic purpura (ITP) completed, wi…
-
CLINICAL_TRIALS trial_result · 2018-11-14Clinical Trial Update: Higher Dose of Rituxan Versus Standard Doses of Rituxan With Cyclophosphamide, Vincristine, and Prednisone in Subjects With Chronic ITP [Phase 2, Phase 3]
Phase 2/3 trial comparing higher dose Rituxan to standard dose Rituxan with CAVOP in immune thrombocytopenic purpura; results completed and …
-
CLINICAL_TRIALS trial_result · 2018-09-07Clinical Trial Update: H. Pylori Eradication for Moderate ITP [Phase 3]
Phase 3 trial investigating Helicobacter pylori eradication for immune thrombocytopenic purpura (ITP).
-
CLINICAL_TRIALS trial_result · 2015-10-19Clinical Trial Update: A Safety Study of Intravenous Immunoglobulin in Patients With Chronic Immune Thrombocytopenic Purpura (ITP) [Phase 4]
A Phase 4 safety study evaluating intravenous immunoglobulin in patients with Immune Thrombocytopenic Purpura has completed and posted resul…